Valuation: GENFIT

Market Cap 683M 790M 638M 585M 1.1B 75.18B 1.12B 7.49B 2.94B 37.68B 2.97B 2.9B 125B P/E 2026 *
35.2x
P/E 2027 * 90.7x
Enterprise Value 632M 731M 590M 542M 1.02B 69.56B 1.03B 6.93B 2.72B 34.86B 2.74B 2.68B 115B EV / Sales 2026 *
6.31x
EV / Sales 2027 * 4.98x
Free-Float
86.88%
Yield 2026 *
-
Yield 2027 * -
1 day-0.44%
1 week-6.82%
Current month-6.82%
1 month+1.49%
3 months+62.62%
6 months+124.12%
Current year+159.45%
1 week 13.56
Extreme 13.56
15.2
1 month 12.34
Extreme 12.34
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/7/23 Buy

Director

5,300 0.0106%
7/7/23 Buy

Chief Executive Officer

10,000 0.0201%
7/7/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%-6.82%+309.23%+294.80% 790M
+0.99%+1.78%+4.07%+16.73% 49.47B
+3.71%+9.40%+486.98%+592.14% 43.61B
+2.70%+1.57%+33.39%+8.85% 39.29B
+5.60%+10.21%+16.76%+85.72% 39.6B
+2.21%+6.75%+21.31%+53.37% 32.43B
+2.23%+4.71% - - 16.84B
+0.97%+2.35%+37.75%+126.84% 16.49B
-0.11%+2.41%+6.24%+18.87% 14.01B
+0.75%+15.04%+78.59%+30.30% 12.77B
Average +1.86%+5.00%+110.48%+136.40% 26.53B
Weighted average by Cap. +2.53%+6.06%+104.91%+141.28%

Financials

2026 *2027 *
Net sales 100M 116M 93.57M 85.84M 161M 11.02B 164M 1.1B 431M 5.53B 435M 425M 18.27B 124M 143M 116M 106M 200M 13.65B 203M 1.36B 533M 6.84B 539M 527M 22.62B
Net income 22.88M 26.45M 21.36M 19.6M 36.86M 2.52B 37.45M 251M 98.38M 1.26B 99.32M 97.15M 4.17B 6.8M 7.86M 6.35M 5.83M 10.96M 748M 11.13M 74.5M 29.24M 375M 29.52M 28.87M 1.24B
Net Debt -51.12M -59.1M -47.74M -43.79M -82.36M -5.62B -83.67M -560M -220M -2.82B -222M -217M -9.32B -66.17M -76.5M -61.8M -56.69M -107M -7.28B -108M -725M -285M -3.65B -287M -281M -12.06B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
07/08/26 EUR 13.66 -0.44% 165,976
06/08/26 EUR 13.72 -2.56% 263,306
05/08/26 EUR 14.08 -1.54% 237,999
04/08/26 EUR 14.30 +1.85% 360,997
03/08/26 EUR 14.04 -4.23% 614,321
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.66EUR
Average target price
15.90EUR
Spread / Average Target
+16.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock